Johannes Czernin - Publications

Affiliations: 
Molec & Med Pharmacology 0639 University of California, Los Angeles, Los Angeles, CA 
Area:
Immunology, Human Development, Biochemistry
Website:
https://www.uclahealth.org/johannes-czernin

238 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Czernin J, Gambhir SS. Discussions with Leaders: A Conversation Between Sam Gambhir and Johannes Czernin. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 59: 1783-1785. PMID 30510073 DOI: 10.2967/jnumed.118.221648  0.44
2018 Maddahi J, Bengel F, Czernin J, Crane P, Dahlbom M, Schelbert H, Sparks R, Phelps M, Lazewatsky J. Dosimetry, biodistribution, and safety of flurpiridaz F 18 in healthy subjects undergoing rest and exercise or pharmacological stress PET myocardial perfusion imaging. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 30488323 DOI: 10.1007/s12350-018-01484-z  1
2018 Polverari G, Ceci F, Allen-Auerbach M, Gupta P, Fishbein MC, Reiter RE, Lee JM, Hope TA, Carroll RM, Czernin J, Calais J. Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by Ga-PSMA-11 PET/CT. Clinical Genitourinary Cancer. PMID 30293922 DOI: 10.1016/j.clgc.2018.09.003  0.44
2017 Antonios JP, Soto H, Everson RG, Moughon DL, Wang AC, Orpilla J, Radu C, Ellingson BM, Lee JT, Cloughesy T, Phelps ME, Czernin J, Liau LM, Prins RM. Detection of immune responses after immunotherapy in glioblastoma using PET and MRI. Proceedings of the National Academy of Sciences of the United States of America. PMID 28874539 DOI: 10.1073/pnas.1706689114  0.48
2017 Calais J, Czernin J, Eiber M, Fendler WP, Gartmann J, Heaney A, Hendifar A, Pisegna J, Hecht JR, Wolin E, Slavik R, Gupta P, Quon A, Schiepers C, Allen-Auerbach M, et al. Most intended management changes after (68)Ga-DOTATATE PET/CT are implemented. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28473600 DOI: 10.2967/jnumed.117.192450  0.52
2017 Fendler WP, Calais J, Allen-Auerbach M, Bluemel C, Eberhardt N, Emmett L, Gupta P, Hartenbach M, Hope TA, Okamoto S, Pfob CH, Pöppel TD, Rischpler C, Schwarzenböck S, Stebner V, ... ... Czernin J, et al. (68)Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28408531 DOI: 10.2967/jnumed.117.190827  0.44
2017 Keu KV, Witney TH, Yaghoubi S, Rosenberg J, Kurien A, Magnusson R, Williams J, Habte F, Wagner JR, Forman S, Brown C, Allen-Auerbach M, Czernin J, Tang W, Jensen MC, et al. Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma. Science Translational Medicine. 9. PMID 28100832 DOI: 10.1126/scitranslmed.aag2196  0.44
2016 Barrio M, Spick C, Radu CG, Lassmann M, Eberlein U, Allen-Auerbach MS, Schiepers C, Slavik R, Czernin J, Herrmann K. Human biodistribution and radiation dosimetry of 18F-CFA, a PET probe targeting the deoxyribonucleoside salvage pathway. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27811125 DOI: 10.2967/jnumed.116.182394  0.52
2016 Forgacs A, Pall Jonsson H, Dahlbom M, Daver F, D DiFranco M, Opposits G, K Krizsan A, Garai I, Czernin J, Varga J, Tron L, Balkay L. A Study on the Basic Criteria for Selecting Heterogeneity Parameters of F18-FDG PET Images. Plos One. 11: e0164113. PMID 27736888 DOI: 10.1371/journal.pone.0164113  0.84
2016 Barrio M, Czernin J, Yeh MW, Palma Diaz MF, Gupta P, Allen-Auerbach M, Schiepers C, Herrmann K. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients. Nuclear Medicine Communications. PMID 27612034 DOI: 10.1097/MNM.0000000000000592  0.52
2016 Fendler WP, Barrio M, Spick C, Allen-Auerbach M, Ambrosini V, Benz M, Bluemel C, Grewal R, Lapa C, Miederer M, Nicolas G, Schuster T, Czernin J, Herrmann K. 68Ga-DOTATATE PET/CT interobserver agreement for neuroendocrine tumor assessments: results from a prospective study on 50 patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 27539839 DOI: 10.2967/jnumed.116.179192  0.44
2016 Kim W, Le TM, Wei L, Poddar S, Bazzy J, Wang X, Uong NT, Abt ER, Capri JR, Austin WR, Van Valkenburgh JS, Steele D, Gipson RM, Slavik R, Cabebe AE, ... ... Czernin J, et al. [18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity. Proceedings of the National Academy of Sciences of the United States of America. PMID 27035974 DOI: 10.1073/pnas.1524212113  0.48
2016 Spick C, Herrmann K, Czernin J. 18F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 57: 420-30. PMID 26742709 DOI: 10.2967/jnumed.115.158808  1
2015 Czernin J. Reply: Roundtable on the Future of Nuclear Medicine Training. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1969-70. PMID 26429954 DOI: 10.2967/jnumed.115.166181  1
2015 Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M. Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 855-61. PMID 25883128 DOI: 10.2967/jnumed.115.156133  1
2015 Herrmann K, Czernin J, Wolin EM, Gupta P, Barrio M, Gutierrez A, Schiepers C, Mosessian S, Phelps ME, Allen-Auerbach MS. Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 70-5. PMID 25500825 DOI: 10.2967/jnumed.114.148247  1
2015 Karavaeva E, Harris RJ, Leu K, Shabihkhani M, Yong WH, Pope WB, Lai A, Nghiemphu PL, Liau LM, Chen W, Czernin J, Cloughesy TF, Ellingson BM. Relationship Between [18F]FDOPA PET Uptake, Apparent Diffusion Coefficient (ADC), and Proliferation Rate in Recurrent Malignant Gliomas. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 17: 434-42. PMID 25465392 DOI: 10.1007/s11307-014-0807-3  1
2014 Karantanis D, Kalkanis D, Czernin J, Herrmann K, Pomykala KL, Bogsrud TV, Subramaniam RM, Lowe VJ, Allen-Auerbach MS. Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1925-9. PMID 25453041 DOI: 10.2967/jnumed.114.145607  1
2014 Nomme J, Li Z, Gipson RM, Wang J, Armijo AL, Le T, Poddar S, Smith T, Santarsiero BD, Nguyen HA, Czernin J, Alexandrova AN, Jung ME, Radu CG, Lavie A. Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability. Journal of Medicinal Chemistry. 57: 9480-94. PMID 25341194 DOI: 10.1021/jm501124j  1
2014 Lapa C, Linsenmann T, Monoranu CM, Samnick S, Buck AK, Bluemel C, Czernin J, Kessler AF, Homola GA, Ernestus RI, Löhr M, Herrmann K. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1611-6. PMID 25125481 DOI: 10.2967/jnumed.114.140608  1
2014 Packard RR, Huang SC, Dahlbom M, Czernin J, Maddahi J. Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1438-44. PMID 25071096 DOI: 10.2967/jnumed.114.141093  1
2014 Czernin J, Ta L, Herrmann K. Does PET/MR Imaging Improve Cancer Assessments? Literature Evidence from More Than 900 Patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 59S-62S. PMID 24812246 DOI: 10.2967/jnumed.114.141838  1
2014 Lajtos I, Czernin J, Dahlbom M, Daver F, Emri M, Farshchi-Heydari S, Forgacs A, Hoh CK, Joszai I, Krizsan AK, Lantos J, Major P, Molnar J, Opposits G, Tron L, et al. Cold wall effect eliminating method to determine the contrast recovery coefficient for small animal PET scanners using the NEMA NU-4 image quality phantom. Physics in Medicine and Biology. 59: 2727-46. PMID 24800813 DOI: 10.1088/0031-9155/59/11/2727  1
2014 Czernin J, Schwaiger M, Townsend D. Introduction. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1S. PMID 24799617 DOI: 10.2967/jnumed.114.142042  1
2014 Mosessian S, Duarte-Vogel SM, Stout DB, Roos KP, Lawson GW, Jordan MC, Ogden A, Matter C, Sadeghi S, Mills GQ, Schelbert HR, Radu CG, Czernin J, Couto M, Phelps ME. INDs for PET molecular imaging probes-approach by an academic institution. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 441-8. PMID 24733693 DOI: 10.1007/s11307-014-0735-2  1
2014 Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Grogan T, Elashoff D, Geist C, Silverman DH, Phelps ME, Chen W. Treatment response evaluation using 18F-FDOPA PET in patients with recurrent malignant glioma on bevacizumab therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 3550-9. PMID 24687922 DOI: 10.1158/1078-0432.CCR-13-1440  1
2014 Bailey DL, Barthel H, Beuthin-Baumann B, Beyer T, Bisdas S, Boellaard R, Czernin J, Drzezga A, Ernemann U, Franzius C, Gückel B, Handgretinger R, Hartenbach M, Hellwig D, Nadel H, et al. Combined PET/MR: Where are we now? Summary report of the second international workshop on PET/MR imaging April 8-12, 2013, Tubingen, Germany. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 16: 295-310. PMID 24668195 DOI: 10.1007/s11307-014-0725-4  1
2014 Chodon T, Comin-Anduix B, Chmielowski B, Koya RC, Wu Z, Auerbach M, Ng C, Avramis E, Seja E, Villanueva A, McCannel TA, Ishiyama A, Czernin J, Radu CG, Wang X, et al. Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 2457-65. PMID 24634374 DOI: 10.1158/1078-0432.CCR-13-3017  1
2014 Nathanson DA, Armijo AL, Tom M, Li Z, Dimitrova E, Austin WR, Nomme J, Campbell DO, Ta L, Le TM, Lee JT, Darvish R, Gordin A, Wei L, Liao HI, ... ... Czernin J, et al. Co-targeting of convergent nucleotide biosynthetic pathways for leukemia eradication. The Journal of Experimental Medicine. 211: 473-86. PMID 24567448 DOI: 10.1084/jem.20131738  1
2014 Karantanis D, Kalkanis D, Allen-Auerbach MS, Herrmann K, Pomykala KL, Bogsrud TV, Lowe VJ, Czernin J. Oncologic PET/CT interpretation and reporting approaches. Survey in clinical practice. Nuklearmedizin. Nuclear Medicine. 53: 19-25. PMID 24473996 DOI: 10.3413/Nukmed-0613-13-07  1
2014 Javed MR, Chen S, Kim HK, Wei L, Czernin J, Kim CJ, van Dam RM, Keng PY. Efficient radiosynthesis of 3'-deoxy-3'-18F-fluorothymidine using electrowetting-on-dielectric digital microfluidic chip. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 321-8. PMID 24365651 DOI: 10.2967/jnumed.113.121053  1
2014 Herrmann K, Czernin J, Cloughesy T, Lai A, Pomykala KL, Benz MR, Buck AK, Phelps ME, Chen W. Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Neuro-Oncology. 16: 603-9. PMID 24305722 DOI: 10.1093/neuonc/not166  1
2014 Lapa C, Linz C, Bluemel C, Mottok A, Mueller-Richter U, Kuebler A, Schneider P, Czernin J, Buck AK, Herrmann K. Three-phase bone scintigraphy for imaging osteoradionecrosis of the jaw. Clinical Nuclear Medicine. 39: 21-5. PMID 24300350 DOI: 10.1097/RLU.0000000000000296  1
2014 Lizarraga KJ, Allen-Auerbach M, Czernin J, DeSalles AA, Yong WH, Phelps ME, Chen W. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 30-6. PMID 24167081 DOI: 10.2967/jnumed.113.121418  1
2013 Ellingson BM, Chen W, Harris RJ, Pope WB, Lai A, Nghiemphu PL, Czernin J, Phelps ME, Cloughesy TF. PET Parametric Response Mapping for Clinical Monitoring and Treatment Response Evaluation in Brain Tumors. Pet Clinics. 8: 201-17. PMID 27157948 DOI: 10.1016/j.cpet.2012.09.002  0.48
2013 Czernin J, Allen-Auerbach M, Nathanson D, Herrmann K. PET/CT in Oncology: Current Status and Perspectives. Current Radiology Reports. 1: 177-190. PMID 24883234 DOI: 10.1007/s40134-013-0016-x  0.44
2013 Allen-Auerbach M, de Vos S, Czernin J. PET/computed tomography and lymphoma. Radiologic Clinics of North America. 51: 833-44. PMID 24010908 DOI: 10.1016/j.rcl.2013.05.004  1
2013 Murphy JM, Armijo AL, Nomme J, Lee CH, Smith QA, Li Z, Campbell DO, Liao HI, Nathanson DA, Austin WR, Lee JT, Darvish R, Wei L, Wang J, Su Y, ... ... Czernin J, et al. Development of new deoxycytidine kinase inhibitors and noninvasive in vivo evaluation using positron emission tomography. Journal of Medicinal Chemistry. 56: 6696-708. PMID 23947754 DOI: 10.1021/jm400457y  1
2013 Amaraesekera B, Marchis PD, Bobinski KP, Radu CG, Czernin J, Barrio JR, Michael van Dam R. High-pressure, compact, modular radiosynthesizer for production of positron emitting biomarkers. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 78: 88-101. PMID 23702794 DOI: 10.1016/j.apradiso.2013.04.024  1
2013 Czernin J, Herrmann K. The potential of PET/MRI imaging in oncology: a comment to a summary report of the First PET/MRI Workshop in Tuebingen in 2012. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 15: 372-3. PMID 23689984 DOI: 10.1007/s11307-013-0642-y  1
2013 Herrmann K, Dahlbom M, Nathanson D, Wei L, Radu C, Chatziioannou A, Czernin J. Evaluation of the Genisys4, a bench-top preclinical PET scanner. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1162-7. PMID 23628700 DOI: 10.2967/jnumed.112.114926  1
2013 Shackelford DB, Abt E, Gerken L, Vasquez DS, Seki A, Leblanc M, Wei L, Fishbein MC, Czernin J, Mischel PS, Shaw RJ. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. Cancer Cell. 23: 143-58. PMID 23352126 DOI: 10.1016/j.ccr.2012.12.008  1
2013 Berman DS, Maddahi J, Tamarappoo BK, Czernin J, Taillefer R, Udelson JE, Gibson CM, Devine M, Lazewatsky J, Bhat G, Washburn D. Phase II safety and clinical comparison with single-photon emission computed tomography myocardial perfusion imaging for detection of coronary artery disease: flurpiridaz F 18 positron emission tomography. Journal of the American College of Cardiology. 61: 469-77. PMID 23265345 DOI: 10.1016/j.jacc.2012.11.022  1
2013 Mocharla VP, Walsh JC, Padgett HC, Su H, Fueger B, Weber WA, Czernin J, Kolb HC. From in situ to in vivo: an in situ click-chemistry-derived carbonic anhydrase II imaging agent for positron emission tomography. Chemmedchem. 8: 43-8. PMID 23208787 DOI: 10.1002/cmdc.201200466  1
2013 Ellingson BM, Chen W, Harris RJ, Pope WB, Lai A, Nghiemphu PL, Czernin J, Phelps ME, Cloughesy TF. PET parametric response mapping for clinical monitoring and treatment response evaluation in brain tumors Pet Clinics. 8: 201-217. DOI: 10.1016/j.cpet.2012.09.002  1
2012 Austin WR, Armijo AL, Campbell DO, Singh AS, Hsieh T, Nathanson D, Herschman HR, Phelps ME, Witte ON, Czernin J, Radu CG. Nucleoside salvage pathway kinases regulate hematopoiesis by linking nucleotide metabolism with replication stress. The Journal of Experimental Medicine. 209: 2215-28. PMID 23148236 DOI: 10.1084/jem.20121061  1
2012 Karantanis D, Kalkanis D, Allen-Auerbach M, Bogsrud TV, Subramaniam RM, Danielson A, Lowe VJ, Czernin J. Oncologic 18F-FDG PET/CT: referring physicians' point of view. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 1499-505. PMID 22917886 DOI: 10.2967/jnumed.111.102228  1
2012 Lee P, Kupelian P, Czernin J, Ghosh P. Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer. Frontiers in Oncology. 2: 71. PMID 22798989 DOI: 10.3389/fonc.2012.00071  1
2012 Harris RJ, Cloughesy TF, Pope WB, Nghiemphu PL, Lai A, Zaw T, Czernin J, Phelps ME, Chen W, Ellingson BM. 18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab. Neuro-Oncology. 14: 1079-89. PMID 22711609 DOI: 10.1093/neuonc/nos141  1
2012 Herschman HR, Czernin J. A spotlight from prostate cancer. Cancer Discovery. 2: 301-3. PMID 22576205 DOI: 10.1158/2159-8290.CD-12-0067  1
2012 Yaghoubi SS, Campbell DO, Radu CG, Czernin J. Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications. Theranostics. 2: 374-91. PMID 22509201 DOI: 10.7150/thno.3677  1
2012 Karantanis D, Allen-Auerbach M, Czernin J. Squamous papilloma of the oral cavity and oropharynx on 18F-FDG PET/CT imaging. Clinical Nuclear Medicine. 37: e98-9. PMID 22475925 DOI: 10.1097/RLU.0b013e318238f52d  1
2012 Wieder H, Freudenberg LS, Czernin J, Navar BN, Israel O, Beyer T. Variations of clinical SPECT/CT operations: an international survey. Nuklearmedizin. Nuclear Medicine. 51: 154-60. PMID 22473174 DOI: 10.3413/Nukmed-0467-12-01  1
2012 Karantanis D, Allen-Auerbach M, Czernin J. Sources and resources for oncologists to help answer the question: is PET/CT appropriate for my patient? Hellenic Journal of Nuclear Medicine. 15: 2-8. PMID 22413105  1
2012 Herrmann K, Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Schuster T, Eckardt JJ, Phelps ME, Weber WA, Eilber FC. 18F-FDG-PET/CT Imaging as an early survival predictor in patients with primary high-grade soft tissue sarcomas undergoing neoadjuvant therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 2024-31. PMID 22338012 DOI: 10.1158/1078-0432.CCR-11-2139  1
2012 Walter F, Cloughesy T, Walter MA, Lai A, Nghiemphu P, Wagle N, Fueger B, Satyamurthy N, Phelps ME, Czernin J. Impact of 3,4-dihydroxy-6-18F-fluoro-L-phenylalanine PET/CT on managing patients with brain tumors: the referring physician's perspective. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 393-8. PMID 22323780 DOI: 10.2967/jnumed.111.095711  1
2012 Lee JT, Campbell DO, Satyamurthy N, Czernin J, Radu CG. Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 275-80. PMID 22302964 DOI: 10.2967/jnumed.111.090407  1
2012 Schwarzenberg J, Czernin J, Cloughesy TF, Ellingson BM, Pope WB, Geist C, Dahlbom M, Silverman DH, Satyamurthy N, Phelps ME, Chen W. 3'-deoxy-3'-18F-fluorothymidine PET and MRI for early survival predictions in patients with recurrent malignant glioma treated with bevacizumab. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 53: 29-36. PMID 22159180 DOI: 10.2967/jnumed.111.092387  1
2012 Karantanis D, Allen-Auerbach M, Czernin J. Relationship among glycolytic phenotype, grade, and histological subtype in ovarian carcinoma. Clinical Nuclear Medicine. 37: 49-53. PMID 22157028 DOI: 10.1097/RLU.0b013e3182291e03  1
2012 Walter F, Czernin J, Hall T, Allen-Auerbach M, Walter MA, Dunkelmann S, Federman N. Is there a need for dedicated bone imaging in addition to 18F-FDG PET/CT imaging in pediatric sarcoma patients? Journal of Pediatric Hematology/Oncology. 34: 131-6. PMID 22134608 DOI: 10.1097/MPH.0b013e3182282825  1
2012 Campbell DO, Yaghoubi SS, Su Y, Lee JT, Auerbach MS, Herschman H, Satyamurthy N, Czernin J, Lavie A, Radu CG. Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe. The Journal of Biological Chemistry. 287: 446-54. PMID 22074768 DOI: 10.1074/jbc.M111.314666  1
2012 Benz MR, Czernin J, Allen-Auerbach MS, Dry SM, Sutthiruangwong P, Spick C, Radu C, Weber WA, Tap WD, Eilber FC. 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response. Cancer. 118: 3135-44. PMID 22020872 DOI: 10.1002/cncr.26630  1
2012 Krizsan AK, Czernin J, Dahlbom M. Whole body PET imaging using variable acquisition times Ieee Nuclear Science Symposium Conference Record. 3931-3934. DOI: 10.1109/NSSMIC.2011.6153747  1
2012 Fueger BJ, Yeom K, Czernin J, Sayre JW, Phelps ME, Allen-Auerbach MS. Response to Larry R. White's letter to the editor titled "comparison of CT, PET, and PET/CT for staging of patientswith indolent non-hodgkin's lymphoma: Statistical errors in Fueger et al. (2009)" Molecular Imaging and Biology. 14: 399-401. DOI: 10.1007/s11307-012-0565-z  1
2011 Herrmann K, Benz MR, Krause BJ, Pomykala KL, Buck AK, Czernin J. (18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can go. The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology. 55: 620-32. PMID 22231582  1
2011 Yang Y, Czernin J. Contribution of imaging to cancer care costs. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 86S-92S. PMID 22144560 DOI: 10.2967/jnumed.110.085621  1
2011 Czernin J, Weber WA. Issues and controversies in nuclear medicine. Introduction. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1S-2S. PMID 22144550 DOI: 10.2967/jnumed.111.097071  1
2011 Bodmann B, Havranek V, Kneussl M, Czernin J, Knoll P, Mirzaei S. Unexpected only pulmonary manifestation of sarcoidosis Nuklearmedizin. 50. PMID 22138706  1
2011 Benz MR, Herrmann K, Walter F, Garon EB, Reckamp KL, Figlin R, Phelps ME, Weber WA, Czernin J, Allen-Auerbach MS. (18)F-FDG PET/CT for monitoring treatment responses to the epidermal growth factor receptor inhibitor erlotinib. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1684-9. PMID 22045706 DOI: 10.2967/jnumed.111.095257  1
2011 Walter F, Federman N, Apichairuk W, Nelson S, Phelps ME, Allen-Auerbach M, Walter MA, Czernin J. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients. Pediatric Hematology and Oncology. 28: 579-87. PMID 21936620 DOI: 10.3109/08880018.2011.602180  1
2011 Wardak M, Schiepers C, Dahlbom M, Cloughesy T, Chen W, Satyamurthy N, Czernin J, Phelps ME, Huang SC. Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 6553-62. PMID 21868765 DOI: 10.1158/1078-0432.CCR-10-3290  1
2011 Maddahi J, Czernin J, Lazewatsky J, Huang SC, Dahlbom M, Schelbert H, Sparks R, Ehlgen A, Crane P, Zhu Q, Devine M, Phelps M. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 1490-8. PMID 21849402 DOI: 10.2967/jnumed.111.092528  1
2011 Ng QK, Su H, Armijo AL, Czernin J, Radu CG, Segura T. Clustered Arg-Gly-Asp peptides enhances tumor targeting of nonviral vectors. Chemmedchem. 6: 623-7. PMID 21442757 DOI: 10.1002/cmdc.201000541  1
2011 Czernin J, Benz MR, Allen-Auerbach MS. Breast cancer. Methods in Molecular Biology (Clifton, N.J.). 727: 141-70. PMID 21331933 DOI: 10.1007/978-1-61779-062-1_9  1
2011 Beyer T, Czernin J, Freudenberg LS. Variations in clinical PET/CT operations: results of an international survey of active PET/CT users. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 303-10. PMID 21233186 DOI: 10.2967/jnumed.110.079624  1
2011 Walter MA, Benz MR, Hildebrandt IJ, Laing RE, Hartung V, Damoiseaux RD, Bockisch A, Phelps ME, Czernin J, Weber WA. Metabolic imaging allows early prediction of response to vandetanib. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 52: 231-40. PMID 21233183 DOI: 10.2967/jnumed.110.081745  1
2011 Schwarzenberg J, Radu CG, Benz M, Fueger B, Tran AQ, Phelps ME, Witte ON, Satyamurthy N, Czernin J, Schiepers C. Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway. European Journal of Nuclear Medicine and Molecular Imaging. 38: 711-21. PMID 21127859 DOI: 10.1007/s00259-010-1666-z  1
2011 Macapinlac HA, Czernin J, Larson SM. Practice based evidence of the beneficial impact of PET in patients with brain tumors. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 13: 1-2. PMID 21082268 DOI: 10.1007/s11307-010-0446-2  1
2010 Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1826-9. PMID 21078790 DOI: 10.2967/jnumed.110.077933  1
2010 Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1532-8. PMID 20847166 DOI: 10.2967/jnumed.110.078592  1
2010 Benz MR, Dry SM, Eilber FC, Allen-Auerbach MS, Tap WD, Elashoff D, Phelps ME, Czernin J. Correlation between glycolytic phenotype and tumor grade in soft-tissue sarcomas by 18F-FDG PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1174-81. PMID 20660389 DOI: 10.2967/jnumed.109.074229  1
2010 Walter MA, Hildebrandt IJ, Hacke K, Kesner AL, Kelly O, Lawson GW, Phelps ME, Czernin J, Weber WA, Schiestl RH. Small-animal PET/CT for monitoring the development and response to chemotherapy of thymic lymphoma in Trp53-/- mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1285-92. PMID 20660381 DOI: 10.2967/jnumed.109.073585  1
2010 Shu CJ, Campbell DO, Lee JT, Tran AQ, Wengrod JC, Witte ON, Phelps ME, Satyamurthy N, Czernin J, Radu CG. Novel PET probes specific for deoxycytidine kinase. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 1092-8. PMID 20554721 DOI: 10.2967/jnumed.109.073361  1
2010 Benz MR, Czernin J, Tap WD, Eckardt JJ, Seeger LL, Allen-Auerbach MS, Dry SM, Phelps ME, Weber WA, Eilber FC. FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas. Sarcoma. 2010: 143540. PMID 20414348 DOI: 10.1155/2010/143540  1
2010 Schiepers C, Dahlbom M, Chen W, Cloughesy T, Czernin J, Phelps ME, Huang SC. Kinetics of 3'-deoxy-3'-18F-fluorothymidine during treatment monitoring of recurrent high-grade glioma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 720-7. PMID 20395318 DOI: 10.2967/jnumed.109.068361  1
2010 Beyer T, Czernin J. Is conflict of interest in our best interest? European Journal of Nuclear Medicine and Molecular Imaging. 37: 1063-8. PMID 20352208 DOI: 10.1007/s00259-010-1429-x  1
2010 Ribas A, Benz MR, Allen-Auerbach MS, Radu C, Chmielowski B, Seja E, Williams JL, Gomez-Navarro J, McCarthy T, Czernin J. Imaging of CTLA4 blockade-induced cell replication with (18)F-FLT PET in patients with advanced melanoma treated with tremelimumab. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 51: 340-6. PMID 20150263 DOI: 10.2967/jnumed.109.070946  1
2010 Czernin J, Benz MR, Allen-Auerbach MS. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination. European Journal of Radiology. 73: 470-80. PMID 20097498 DOI: 10.1016/j.ejrad.2009.12.023  1
2010 Toy G, Austin WR, Liao HI, Cheng D, Singh A, Campbell DO, Ishikawa TO, Lehmann LW, Satyamurthy N, Phelps ME, Herschman HR, Czernin J, Witte ON, Radu CG. Requirement for deoxycytidine kinase in T and B lymphocyte development. Proceedings of the National Academy of Sciences of the United States of America. 107: 5551-6. PMID 20080663 DOI: 10.1073/pnas.0913900107  1
2010 Benz MR, Czernin J, Dry SM, Tap WD, Allen-Auerbach MS, Elashoff D, Phelps ME, Weber WA, Eilber FC. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer. 116: 451-8. PMID 19924789 DOI: 10.1002/cncr.24755  1
2010 Benz MR, Czernin J, Dry SM, Tap WD, Allen-Auerbach MS, Elashoff D, Phelps ME, Weber WA, Eilber FC. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign (Cancer (2010) 116, (451-458)) Cancer. 116: 775. DOI: 10.1002/cncr.24911  1
2009 Czernin J, Benz MR, Allen-Auerbach MS. PET Imaging of Prostate Cancer Using C-Acetate. Pet Clinics. 4: 163-172. PMID 21984877 DOI: 10.1016/j.cpet.2009.05.001  1
2009 Guo D, Hildebrandt IJ, Prins RM, Soto H, Mazzotta MM, Dang J, Czernin J, Shyy JY, Watson AD, Phelps M, Radu CG, Cloughesy TF, Mischel PS. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Proceedings of the National Academy of Sciences of the United States of America. 106: 12932-7. PMID 19625624 DOI: 10.1073/pnas.0906606106  1
2009 Schluep T, Hwang J, Hildebrandt IJ, Czernin J, Choi CH, Alabi CA, Mack BC, Davis ME. Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements. Proceedings of the National Academy of Sciences of the United States of America. 106: 11394-9. PMID 19564622 DOI: 10.1073/pnas.0905487106  1
2009 Wang H, Wang S, Su H, Chen KJ, Armijo AL, Lin WY, Wang Y, Sun J, Kamei K, Czernin J, Radu CG, Tseng HR. A supramolecular approach for preparation of size-controlled nanoparticles. Angewandte Chemie (International Ed. in English). 48: 4344-8. PMID 19425037 DOI: 10.1002/anie.200900063  1
2009 Benz MR, Tchekmedyian N, Eilber FC, Federman N, Czernin J, Tap WD. Utilization of positron emission tomography in the management of patients with sarcoma. Current Opinion in Oncology. 21: 345-51. PMID 19412096 DOI: 10.1097/CCO.0b013e32832c95e2  1
2009 Johnson M, Karanikolas BD, Priceman SJ, Powell R, Black ME, Wu HM, Czernin J, Huang SC, Wu L. Titration of variant HSV1-tk gene expression to determine the sensitivity of 18F-FHBG PET imaging in a prostate tumor. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 757-64. PMID 19372484 DOI: 10.2967/jnumed.108.058438  1
2009 Benz MR, Czernin J, Allen-Auerbach MS, Tap WD, Dry SM, Elashoff D, Chow K, Evilevitch V, Eckardt JJ, Phelps ME, Weber WA, Eilber FC. FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 2856-63. PMID 19351756 DOI: 10.1158/1078-0432.CCR-08-2537  1
2009 Fueger BJ, Yeom K, Czernin J, Sayre JW, Phelps ME, Allen-Auerbach MS. Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 11: 269-74. PMID 19326177 DOI: 10.1007/s11307-009-0200-9  1
2009 Dumont RA, Hildebrandt I, Su H, Haubner R, Reischl G, Czernin JG, Mischel PS, Weber WA. Noninvasive imaging of alphaVbeta3 function as a predictor of the antimigratory and antiproliferative effects of dasatinib. Cancer Research. 69: 3173-9. PMID 19318569 DOI: 10.1158/0008-5472.CAN-08-3390  1
2009 Imani F, Agopian VG, Auerbach MS, Walter MA, Imani F, Benz MR, Dumont RA, Lai CK, Czernin JG, Yeh MW. 18F-FDOPA PET and PET/CT accurately localize pheochromocytomas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 50: 513-9. PMID 19289420 DOI: 10.2967/jnumed.108.058396  1
2009 Laing RE, Walter MA, Campbell DO, Herschman HR, Satyamurthy N, Phelps ME, Czernin J, Witte ON, Radu CG. Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography. Proceedings of the National Academy of Sciences of the United States of America. 106: 2847-52. PMID 19196993 DOI: 10.1073/pnas.0812890106  1
2009 Yaghoubi SS, Jensen MC, Satyamurthy N, Budhiraja S, Paik D, Czernin J, Gambhir SS. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma. Nature Clinical Practice. Oncology. 6: 53-8. PMID 19015650 DOI: 10.1038/ncponc1278  1
2009 Ledezma CJ, Chen W, Sai V, Freitas B, Cloughesy T, Czernin J, Pope W. 18F-FDOPA PET/MRI fusion in patients with primary/recurrent gliomas: initial experience. European Journal of Radiology. 71: 242-8. PMID 18511228 DOI: 10.1016/j.ejrad.2008.04.018  1
2009 Kesner AL, Bundschuh RA, Detorie NC, Dahlbom M, Ziegler SI, Czernin J, Silverman DH. Respiratory gated PET derived in a fully automated manner from raw PET data Ieee Transactions On Nuclear Science. 56: 677-686. DOI: 10.1109/TNS.2009.2016341  1
2009 Czernin J. Guest editorial: Implications of the recent CMS PET coverage decision Applied Radiology. 38: 4-5.  1
2009 Yaghoubi SS, Jensen MC, Satyamurthy N, Budhiraja S, Paik D, Czernin J, Gambhir SS. Noninvasive detection of therapeutic cytolytic T cells with 18 F-FHBG PET in a patient with glioma Nature Reviews Clinical Oncology. 6: 53-58.  1
2008 Wei LH, Olafsen T, Radu C, Hildebrandt IJ, McCoy MR, Phelps ME, Meares C, Wu AM, Czernin J, Weber WA. Engineered antibody fragments with infinite affinity as reporter genes for PET imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1828-35. PMID 18927335 DOI: 10.2967/jnumed.108.054452  1
2008 Benz MR, Allen-Auerbach MS, Eilber FC, Chen HJ, Dry S, Phelps ME, Czernin J, Weber WA. Combined assessment of metabolic and volumetric changes for assessment of tumor response in patients with soft-tissue sarcomas. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1579-84. PMID 18794268 DOI: 10.2967/jnumed.108.053694  1
2008 Kesner AL, Lau VK, Speiser M, Hsueh WA, Agazaryan N, DeMarco JJ, Czernin J, Silverman DH. Time-course of effects of external beam radiation on [18F]FDG uptake in healthy tissue and bone marrow. Journal of Applied Clinical Medical Physics / American College of Medical Physics. 9: 2747. PMID 18716585  1
2008 Kesner AL, Hsueh WA, Czernin J, Padgett H, Phelps ME, Silverman DH. Radiation dose estimates for [18F]5-fluorouracil derived from PET-based and tissue-based methods in rats. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 10: 341-8. PMID 18679756 DOI: 10.1007/s11307-008-0160-5  1
2008 Allen-Auerbach M, de Vos S, Czernin J. The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients. Radiologic Clinics of North America. 46: 199-211, vii. PMID 18619376 DOI: 10.1016/j.rcl.2008.03.004  1
2008 Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J, Weber WA. Treatment monitoring by 18F-FDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 49: 1038-46. PMID 18552153 DOI: 10.2967/jnumed.107.050187  1
2008 Wei LH, Su H, Hildebrandt IJ, Phelps ME, Czernin J, Weber WA. Changes in tumor metabolism as readout for Mammalian target of rapamycin kinase inhibition by rapamycin in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3416-26. PMID 18519772 DOI: 10.1158/1078-0432.CCR-07-1824  1
2008 Weber WA, Grosu AL, Czernin J. Technology Insight: advances in molecular imaging and an appraisal of PET/CT scanning. Nature Clinical Practice. Oncology. 5: 160-70. PMID 18253106 DOI: 10.1038/ncponc1041  1
2008 Evilevitch V, Weber WA, Tap WD, Allen-Auerbach M, Chow K, Nelson SD, Eilber FR, Eckardt JJ, Elashoff RM, Phelps ME, Czernin J, Eilber FC. Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 715-20. PMID 18245531 DOI: 10.1158/1078-0432.CCR-07-1762  1
2008 Su H, Seimbille Y, Ferl GZ, Bodenstein C, Fueger B, Kim KJ, Hsu YT, Dubinett SM, Phelps ME, Czernin J, Weber WA. Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors. European Journal of Nuclear Medicine and Molecular Imaging. 35: 1089-99. PMID 18239919 DOI: 10.1007/s00259-007-0636-6  1
2008 Weber WA, Czernin J, Phelps ME, Herschman HR. Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs. Nature Clinical Practice. Oncology. 5: 44-54. PMID 18097456 DOI: 10.1038/ncponc0982  1
2007 Kesner AL, Hsueh WA, Htet NL, Pio BS, Czernin J, Pegram MD, Phelps ME, Silverman DH. Biodistribution and predictive value of 18F-fluorocyclophosphamide in mice bearing human breast cancer xenografts. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 2021-7. PMID 18006620 DOI: 10.2967/jnumed.107.045716  1
2007 Chen W, Delaloye S, Silverman DH, Geist C, Czernin J, Sayre J, Satyamurthy N, Pope W, Lai A, Phelps ME, Cloughesy T. Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 25: 4714-21. PMID 17947718 DOI: 10.1200/JCO.2006.10.5825  1
2007 Weber WA, Czernin J, Phelps ME. Prognostic significance of fluorodeoxyglucose uptake in non-small cell lung cancer. A blurry picture? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 3105-6. PMID 17545510 DOI: 10.1158/1078-0432.CCR-07-0188  1
2007 Lin TW, de Aburto MA, Dahlbom M, Huang LL, Marvi MM, Tang M, Czernin J, Phelps ME, Silverman DH. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery: prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 776-82. PMID 17475967 DOI: 10.2967/jnumed.106.034249  1
2007 Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, Czernin J, Schiepers C. Accuracy of PET/CT in characterization of solitary pulmonary lesions. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 214-20. PMID 17268017  1
2007 Halpern BS, Yeom K, Fueger BJ, Lufkin RB, Czernin J, Allen-Auerbach M. Evaluation of suspected local recurrence in head and neck cancer: a comparison between PET and PET/CT for biopsy proven lesions. European Journal of Radiology. 62: 199-204. PMID 17223003 DOI: 10.1016/j.ejrad.2006.11.037  1
2007 Czernin J, Allen-Auerbach M, Schelbert HR. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 78S-88S. PMID 17204723  1
2007 Czernin J, Schelbert HR. PET/CT in cancer patient management. Introduction. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 48: 2S-3S. PMID 17204715  1
2007 Kesner AL, Dahlbom M, Czernin J, Silverman DHS. Recombining respiratory gated PET frames Ieee Nuclear Science Symposium Conference Record. 5: 3961-3963. DOI: 10.1109/NSSMIC.2007.4436984  1
2007 Kesner AL, Bundschuh RA, Detorie NC, Dahlbom M, Czernin J, Silverman DHS. Respiratory gated PET derived from raw PET data Ieee Nuclear Science Symposium Conference Record. 4: 2686-2691. DOI: 10.1109/NSSMIC.2007.4436699  1
2007 Czernin J, Schelbert HR. Journal of Nuclear Medicine: Introduction Journal of Nuclear Medicine. 48.  1
2006 Hsueh WA, Kesner AL, Gangloff A, Pegram MD, Beryt M, Czernin J, Phelps ME, Silverman DH. Predicting chemotherapy response to paclitaxel with 18F-Fluoropaclitaxel and PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 1995-9. PMID 17138742  1
2006 Su H, Bodenstein C, Dumont RA, Seimbille Y, Dubinett S, Phelps ME, Herschman H, Czernin J, Weber W. Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 5659-67. PMID 17020967 DOI: 10.1158/1078-0432.CCR-06-0368  1
2006 Kesner AL, Dahlbom M, Huang SC, Hsueh WA, Pio BS, Czernin J, Kreissl M, Wu HM, Silverman DH. Semiautomated analysis of small-animal PET data. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 1181-6. PMID 16818953  1
2006 Fueger BJ, Czernin J, Hildebrandt I, Tran C, Halpern BS, Stout D, Phelps ME, Weber WA. Impact of animal handling on the results of 18F-FDG PET studies in mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 999-1006. PMID 16741310  1
2006 Chen W, Silverman DH, Delaloye S, Czernin J, Kamdar N, Pope W, Satyamurthy N, Schiepers C, Cloughesy T. 18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 904-11. PMID 16741298  1
2006 Yap CS, Czernin J, Fishbein MC, Cameron RB, Schiepers C, Phelps ME, Weber WA. Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography. Chest. 129: 393-401. PMID 16478857 DOI: 10.1378/chest.129.2.393  1
2006 Allen-Auerbach M, Yeom K, Park J, Phelps M, Czernin J. Standard PET/CT of the chest during shallow breathing is inadequate for comprehensive staging of lung cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 298-301. PMID 16455636  1
2006 Czernin J, Weber WA, Herschman HR. Molecular imaging in the development of cancer therapeutics. Annual Review of Medicine. 57: 99-118. PMID 16409139 DOI: 10.1146/annurev.med.57.080904.190431  1
2006 Pio BS, Park CK, Pietras R, Hsueh WA, Satyamurthy N, Pegram MD, Czernin J, Phelps ME, Silverman DH. Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 8: 36-42. PMID 16362149 DOI: 10.1007/s11307-005-0029-9  1
2006 Thomas GV, Tran C, Mellinghoff IK, Welsbie DS, Chan E, Fueger B, Czernin J, Sawyers CL. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nature Medicine. 12: 122-7. PMID 16341243 DOI: 10.1038/nm1337  1
2006 Azarian V, Gangloff A, Seimbille Y, Delaloye S, Czernin J, Phelps ME, Silverman DHS. Synthesis and liposome encapsulation of a novel 18F-conjugate of ω-conotoxin GVIA for the potential imaging of N-type Ca2+ channels in the brain by positron emission tomography Journal of Labelled Compounds and Radiopharmaceuticals. 49: 269-283. DOI: 10.1002/jlcr.1029  1
2005 Czernin J, Auerbach MA. Clinical PET/CT imaging: Promises and misconceptions Nuklearmedizin. 44. PMID 16395974  1
2005 Gangloff A, Hsueh WA, Kesner AL, Kiesewetter DO, Pio BS, Pegram MD, Beryt M, Townsend A, Czernin J, Phelps ME, Silverman DH. Estimation of paclitaxel biodistribution and uptake in human-derived xenografts in vivo with (18)F-fluoropaclitaxel. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 1866-71. PMID 16269601  1
2005 Halpern BS, Schiepers C, Weber WA, Crawford TL, Fueger BJ, Phelps ME, Czernin J. Presurgical staging of non-small cell lung cancer: positron emission tomography, integrated positron emission tomography/CT, and software image fusion. Chest. 128: 2289-97. PMID 16236886 DOI: 10.1378/chest.128.4.2289  1
2005 Fueger BJ, Weber WA, Quon A, Crawford TL, Allen-Auerbach MS, Halpern BS, Ratib O, Phelps ME, Czernin J. Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 7: 369-76. PMID 16220355 DOI: 10.1007/s11307-005-0013-4  1
2005 Tran A, Pio BS, Khatibi B, Czernin J, Phelps ME, Silverman DH. 18F-FDG PET for staging breast cancer in patients with inner-quadrant versus outer-quadrant tumors: comparison with long-term clinical outcome. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 1455-9. PMID 16157527  1
2005 Brunken RC, Perloff JK, Czernin J, Campisi R, Purcell S, Miner PD, Child JS, Schelbert HR. Myocardial perfusion reserve in adults with cyanotic congenital heart disease. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1798-806. PMID 16006539 DOI: 10.1152/ajpheart.01309.2004  1
2005 Halpern BS, Dahlbom M, Auerbach MA, Schiepers C, Fueger BJ, Weber WA, Silverman DH, Ratib O, Czernin J. Optimizing imaging protocols for overweight and obese patients: a lutetium orthosilicate PET/CT study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 603-7. PMID 15809482  1
2005 Kim JH, Czernin J, Allen-Auerbach MS, Halpern BS, Fueger BJ, Hecht JR, Ratib O, Phelps ME, Weber WA. Comparison between 18F-FDG PET, in-line PET/CT, and software fusion for restaging of recurrent colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 587-95. PMID 15809480  1
2005 Waldherr C, Mellinghoff IK, Tran C, Halpern BS, Rozengurt N, Safaei A, Weber WA, Stout D, Satyamurthy N, Barrio J, Phelps ME, Silverman DH, Sawyers CL, Czernin J. Monitoring antiproliferative responses to kinase inhibitor therapy in mice with 3'-deoxy-3'-18F-fluorothymidine PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 46: 114-20. PMID 15632041  1
2005 Ratib O, Rosset A, Dahlbom M, Czernin J. Navigating the fifth dimension: New concepts in interactive multimodality and multidimensional image navigation Progress in Biomedical Optics and Imaging - Proceedings of Spie. 5748: 28-32. DOI: 10.1117/12.594648  1
2005 Dahlbom M, Schiepers C, Czernin J. Comparison of noise equivalent count rates and image noise Ieee Transactions On Nuclear Science. 52: 1386-1390. DOI: 10.1109/TNS.2005.858176  1
2005 Seimbille Y, Phelps ME, Czernin J, Silverman DHS. Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: Synthesis of18F-Iressa and related molecular probes Journal of Labelled Compounds and Radiopharmaceuticals. 48: 829-843. DOI: 10.1002/jlcr.998  1
2005 Seimbille Y, Czernin J, Phelps ME, Silverman DHS. Synthesis of an18F-fluorobenzoate idarubicin derivative as new potential PET radiotracer to predict chemotherapy resistance Journal of Labelled Compounds and Radiopharmaceuticals. 48: 819-827. DOI: 10.1002/jlcr.990  1
2005 Lacan G, Kesner AL, Gangloff A, Zheng L, Czernin J, Melega WP, Silverman DHS. Synthesis of 2-[(2-chloro-2′-[18F]fluoroethyl)amino]-2H-1, 3,2-oxazaphosphorinane-2-oxide (18F-fluorocyclophosphamide), a potential tracer for breast tumor prognostic imaging with PET Journal of Labelled Compounds and Radiopharmaceuticals. 48: 635-643. DOI: 10.1002/jlcr.954  1
2004 Czernin J, Weber W. Translational molecular imaging Molecular Imaging and Biology. 6: 181-182. PMID 15262232 DOI: 10.1016/j.mibio.2004.06.001  1
2004 Obrzut SL, Halpern BS, Monchamp T, Grabski K, Watts WJ, Czernin J. The role of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography/computed tomography in monitoring the immunosuppressive therapy response of inflammatory myofibroblastic tumor. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 6: 126-30. PMID 15193246 DOI: 10.1016/j.mibio.2004.03.003  1
2004 Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH, Ratib O, Czernin J. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 45: 797-801. PMID 15136629  1
2004 Filmont JE, Yap CS, Ko F, Vranjesevic D, Quon A, Margolis DJ, Safaei A, Emmanouilides C, Silverman DH, Phelps ME, Czernin J. Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 6: 47-54. PMID 15018828 DOI: 10.1016/S1536-1632(03)00107-0  1
2004 Halpern BS, Dahlbom M, Waldherr C, Yap CS, Schiepers C, Silverman DH, Ratib O, Czernin J. Cardiac pacemakers and central venous lines can induce focal artifacts on CT-corrected PET images. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 45: 290-3. PMID 14960650  1
2004 Czernin J, Vranjesevic D. Reply [2] Journal of Nuclear Medicine. 45: 1423-1424.  1
2004 Halpern BS, Abemayor E, Lufkin RB, Czernin J. Detection of small metastatic lymph nodes by PET/CT in a patient with medullary thyroid carcinoma Nuklearmedizin. 43: N1-N3.  1
2003 Silverman DH, Truong CT, Kim SK, Chang CY, Chen W, Kowell AP, Cummings JL, Czernin J, Small GW, Phelps ME. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Molecular Genetics and Metabolism. 80: 350-5. PMID 14680983 DOI: 10.1016/S1096-7192(03)00139-2  1
2003 Filmont JE, Vranjesevic D, Quon A, Margolis DJ, Ko F, Safaei A, Emmanouilides C, Silverman DH, Rao J, Valk PE, Phelps ME, Czernin J. Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patients. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 5: 232-9. PMID 14499138 DOI: 10.1016/S1536-1632(03)00086-6  1
2003 Filmont JE, Czernin J, Yap C, Silverman DH, Quon A, Phelps ME, Emmanouilides C. Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation. Chest. 124: 608-13. PMID 12907550 DOI: 10.1378/chest.124.2.608  1
2003 Vranjesevic D, Schiepers C, Silverman DH, Quon A, Villalpando J, Dahlbom M, Phelps ME, Czernin J. Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 44: 1238-42. PMID 12902413  1
2003 Schiepers C, Filmont JE, Czernin J. PET for staging of Hodgkin's disease and non-Hodgkin's lymphoma European Journal of Nuclear Medicine and Molecular Imaging. 30. PMID 12719922  1
2003 Czernin J, Waldherr C. Cigarette smoking and coronary blood flow Progress in Cardiovascular Diseases. 45: 395-404. PMID 12704596 DOI: 10.1053/pcad.2003.00104  1
2003 Dahlbom M, Schiepers C, Ratib O, Czernin J. Estimation of relative PET system sensitivity based on image noise Ieee Nuclear Science Symposium Conference Record. 4: 2574-2577.  1
2002 Silverman DH, Cummings JL, Small GW, Gambhir SS, Chen W, Czernin J, Phelps ME. Added clinical benefit of incorporating 2-deoxy-2-[18F]fluoro-D-glucose with positron emission tomography into the clinical evaluation of patients with cognitive impairment. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 4: 283-93. PMID 14537119 DOI: 10.1016/S1536-1632(02)00016-1  1
2002 Czernin J. Clinical applications of FDG-PET in oncology Acta Medica Austriaca. 29: 162-170. PMID 12506767 DOI: 10.1046/j.1563-2571.2002.02042.x  1
2002 Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? European Journal of Nuclear Medicine and Molecular Imaging. 29: 1166-73. PMID 12192561 DOI: 10.1007/s00259-002-0853-y  1
2002 Seltzer MA, Yap CS, Silverman DH, Meta J, Schiepers C, Phelps ME, Gambhir SS, Rao J, Valk PE, Czernin J. The impact of PET on the management of lung cancer: the referring physician's perspective. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 752-6. PMID 12050318  1
2002 Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, Valk PE, Czernin J. Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 325-9. PMID 11884491  1
2002 Silverman DH, Gambhir SS, Huang HW, Schwimmer J, Kim S, Small GW, Chodosh J, Czernin J, Phelps ME. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 43: 253-66. PMID 11850493  1
2002 Safaei A, Figlin R, Hoh CK, Silverman DH, Seltzer M, Phelps ME, Czernin J. The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clinical Nephrology. 57: 56-62. PMID 11837802  1
2002 Czernin J, Phelps ME. Positron emission tomography scanning: current and future applications. Annual Review of Medicine. 53: 89-112. PMID 11818465 DOI: 10.1146/annurev.med.53.082901.104028  1
2002 Schöder H, Brown K, Said J, Czernin J. A patient with primary cardiac lymphoma Molecular Imaging and Biology. 4: 274-275. DOI: 10.1016/S1536-1632(02)00009-4  1
2002 Wong C, Silverman DH, Seltzer M, Schiepers C, Ariannejad M, Gambhir SS, Phelps ME, Rao J, Valk P, Czernin J. The impact of 2-deoxy-2[18F]fluoro-D-glucose whole body positron emission tomography for managing patients with melanoma: The referring physician's perspective Molecular Imaging and Biology. 4: 185-190. DOI: 10.1016/S1536-1632(01)00003-8  1
2002 Czernin J. FDG-PET in breast cancer: A different view of its clinical usefulness Molecular Imaging and Biology. 4: 35-45. DOI: 10.1016/S1095-0397(01)00069-3  1
2001 Yap CS, Seltzer MA, Schiepers C, Gambhir SS, Rao J, Phelps ME, Valk PE, Czernin J. Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 42: 1334-7. PMID 11535721  1
2001 Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME. A tabulated summary of the FDG PET literature. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 42: 1S-93S. PMID 11483694  1
2001 Schöder H, Meta J, Yap C, Ariannejad M, Rao J, Phelps ME, Valk PE, Sayre J, Czernin J. Effect of whole-body (18)F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 42: 1139-43. PMID 11483671  1
2001 Meta J, Seltzer M, Schiepers C, Silverman DH, Ariannejad M, Gambhir SS, Phelps ME, Valk P, Czernin J. Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 42: 586-90. PMID 11337546  1
2001 Kwan A, Seltzer M, Czernin J, Ming Jen Chou, Kao CH. Characterization of hilar lymph node by 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects Anticancer Research. 21: 701-706. PMID 11299829  1
2001 Park KC, Schwimmer J, Shepherd JE, Phelps ME, Czernin JR, Schiepers C, Gambhir SS. Decision analysis for the cost-effective management of recurrent colorectal cancer. Annals of Surgery. 233: 310-9. PMID 11224617 DOI: 10.1097/00000658-200103000-00003  0.52
2000 Madsen MM, Bøttcher M, Nielsen TT, Czernin J. Altered regulation of the myocardial microcirculation in young smokers Cardiology. 94: 91-98. PMID 11173779 DOI: 10.1159/000047298  1
2000 Schwimmer J, Essner R, Patel A, Jahan SA, Shepherd JE, Park K, Phelps ME, Czernin J, Gambhir SS. A review of the literature for whole-body FDG PET in the management of patients with melanoma. The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (Aimn) [and] the International Association of Radiopharmacology (Iar). 44: 153-67. PMID 10967625  1
2000 Huebner RH, Park KC, Shepherd JE, Schwimmer J, Czernin J, Phelps ME, Gambhir SS. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 41: 1177-89. PMID 10914907  1
2000 Schöder H, Silverman DH, Campisi R, Sayre JW, Phelps ME, Schelbert HR, Czernin J. Regulation of myocardial blood flow response to mental stress in healthy individuals. American Journal of Physiology. Heart and Circulatory Physiology. 278: H360-6. PMID 10666065  1
2000 Schöder H, Silverman DH, Campisi R, Karpman H, Phelps ME, Schelbert HR, Czernin J. Effect of mental stress on myocardial blood flow and vasomotion in patients with coronary artery disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 41: 11-6. PMID 10647599  1
1999 Farquhar TH, Llacer J, Hoh CK, Czernin J, Gambhir SS, Seltzer MA, Silverman DH, Qi J, Hsu C, Hoffman EJ. ROC and localization ROC analyses of lesion detection in whole-body FDG PET: effects of acquisition mode, attenuation correction and reconstruction algorithm. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 40: 2043-52. PMID 10616885  1
1999 Porenta G, Cherry S, Czernin J, Brunken R, Kuhle W, Hashimoto T, Schelbert HR. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging European Journal of Nuclear Medicine. 26: 1465-1474. PMID 10552089 DOI: 10.1007/s002590050480  1
1999 Auerbach MA, Schöder H, Hoh C, Gambhir SS, Yaghoubi S, Sayre JW, Silverman D, Phelps ME, Schelbert HR, Czernin J. Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy. Circulation. 99: 2921-6. PMID 10359737  1
1999 Allen-Auerbach M, Schöder H, Johnson J, Kofoed K, Einhorn K, Phelps ME, Kobashigawa J, Czernin J. Relationship between coronary function by positron emission tomography and temporal changes in morphology by intravascular ultrasound (IVUS) in transplant recipients. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society For Heart Transplantation. 18: 211-9. PMID 10328146 DOI: 10.1016/S1053-2498(98)00037-0  1
1999 Bøttcher M, Bøtker HE, Sonne H, Nielsen TT, Czernin J. Endothelium-dependent and -independent perfusion reserve and the effect of L-arginine on myocardial perfusion in patients with syndrome X Circulation. 99: 1795-1801. PMID 10199874  1
1999 Schöder H, Campisi R, Ohtake T, Hoh CK, Moon DH, Czernin J, Schelbert HR. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction Journal of the American College of Cardiology. 33: 1328-1337. PMID 10193735 DOI: 10.1016/S0735-1097(99)00010-8  1
1999 Campisi R, Czernin J, Schöder H, Sayre JW, Scheiben HR. L-arginine normalizes coronary vasomotion in long-term smokers Circulation. 99: 491-497. PMID 9927394  1
1998 Campisi R, Czernin J, Schöder H, Sayre JW, Marengo FD, Phelps ME, Schelbert HR. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation. 98: 119-25. PMID 9679717  1
1998 Silverman DH, Hoh CK, Seltzer MA, Schiepers C, Cuan GS, Gambhir SS, Zheng L, Czernin J, Phelps ME. Evaluating tumor biology and oncological disease with positron-emission tomography. Seminars in Radiation Oncology. 8: 183-96. PMID 9634495 DOI: 10.1016/S1053-4296(98)80044-1  1
1998 Hoh CK, Seltzer MA, Ting Au Yong, Czernin J, Silverman DHS, Gambhir SS, Phelps ME, Karlan BY. Positron emission tomography in gynecologic malignancies Journal of Gynecologic Techniques. 4: 19-24.  1
1997 Campisi R, Czernin J, Karpman HL, Schelbert HR. Coronary vasodilatory capacity and flow reserve in normal myocardium supplied by bypass grafts late after surgery American Journal of Cardiology. 80: 27-31. PMID 9205015 DOI: 10.1016/S0002-9149(97)00278-6  1
1997 Hoh CK, Schiepers C, Seltzer MA, Gambhir SS, Silverman DH, Czernin J, Maddahi J, Phelps ME. PET in oncology: will it replace the other modalities? Seminars in Nuclear Medicine. 27: 94-106. PMID 9144854  1
1997 Böttcher M, Czernin J, Sun K, Phelps ME, Schelbert HR. Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 38: 442-6. PMID 9074535  1
1997 Kofoed KF, Czernin J, Johnson J, Kobashigawa J, Phelps ME, Laks H, Schelbert HR. Effects of cardiac allograft vasculopathy on myocardial blood flow, vasodilatory capacity, and coronary vasomotion. Circulation. 95: 600-6. PMID 9024146  1
1997 Chan MT, Leahy RM, Mumcuoglu EU, Cherry SR, Czernin J, Chatziioannou A. Comparing lesion detection performance for PET image reconstruction algorithms: A case study Ieee Transactions On Nuclear Science. 44: 1558-1562. DOI: 10.1109/23.632731  1
1996 Maddahi J, Czernin J. Absolute quantitation of myocardial blood flow: The technical and clinical prospects for single-photon emission computed tomography Journal of Nuclear Cardiology. 3. PMID 8989688 DOI: 10.1016/S1071-3581(96)90209-3  1
1996 Sun KT, Czernin J, Krivokapich J, Lau YK, Böttcher M, Maurer G, Phelps ME, Schelbert HR. Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium. Circulation. 94: 3146-54. PMID 8989122  1
1996 Weismüller S, Czernin J, Sun KT, Fung C, Phelps ME, Schelbert HR. Coronary vasodilatory capacity is impaired in patients with dilated cardiomyopathy. American Journal of Cardiac Imaging. 10: 154-62. PMID 8914701  1
1996 Nagamachi S, Czernin J, Kim AS, Sun KT, Böttcher M, Phelps ME, Schelbert HR. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 37: 1626-31. PMID 8862296  1
1996 Krivokapich J, Czernin J, Schelbert HR. Dobutamine positron emission tomography: Absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease Journal of the American College of Cardiology. 28: 565-572. PMID 8772740 DOI: 10.1016/S0735-1097(96)00205-7  1
1996 Nitzsche EU, Choi Y, Czernin J, Hoh CK, Huang SC, Schelbert HR. Noninvasive Quantification of Myocardial Blood Flow in Humans: A Direct Comparison of the [13N] Ammonia and the [15O]Water Techniques Circulation. 93: 2000-2006. PMID 8640974  1
1996 Yang J, Huang SC, Lin KP, Czernin J, Wolfenden P, Dahlbom M, Höh CK, Phelps ME. A new axial smoothing method based on elastic mapping Ieee Transactions On Nuclear Science. 43: 3355-3360.  1
1995 Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Schelbert HR. Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation. 91: 1944-51. PMID 7895351  1
1995 Sinha S, Sinha U, Czernin J, Porenta G, Schelbert HR. Noninvasive assessment of myocardial perfusion and metabolism: Feasibility of registering gated MR and PET images American Journal of Roentgenology. 164: 301-307. PMID 7839959  1
1995 Czernin J, Sun K, Brunken R, Bottcher M, Phelps M, Schelbert H. Effect of acute and long-term smoking on myocardial blood flow and flow reserve Circulation. 91: 2891-2897. PMID 7796497  1
1995 Porenta G, Kuhle W, Sinha S, Krivokapich J, Czernin J, Gambhir SS, Phelps ME, Schelbert HR. Parameter estimation of cardiac geometry by ECG-gated PET imaging: validation using magnetic resonance imaging and echocardiography. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 1123-9. PMID 7769438  1
1995 Czernin J, Barnard RJ, Sun KT, Krivokapich J, Nitzsche E, Dorsey D, Phelps ME, Schelbert HR. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation. 92: 197-204. PMID 7600651  1
1995 Böttcher M, Czernin J, Sun KT, Phelps ME, Schelbert HR. Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 36: 2016-21. PMID 7472591  1
1995 Yang J, Huang SC, Lin KP, Czernin J, Wolfenden P, Dahlbom M, Hoh CK, Phelps ME. New axial smoothing method based on elastic mapping Ieee Nuclear Science Symposium &Amp; Medical Imaging Conference. 3: 1420-1424.  1
1994 Steger GG, Pierce WC, Figlin R, Czernin J, Kaboo R, DeKernion JB, Okarma T, Belldegrun A. Patterns of cytokine release of unselected and CD8+ selected renal cell carcinoma tumor-infiltrating lymphocytes (TIL). Evidence for enhanced specific killing of tumor necrosis factor-secreting/IL-6. Nonsecreting TIL in vitro and correlation with complete response in vivo Clinical Immunology and Immunopathology. 72: 237-247. PMID 8050198 DOI: 10.1006/clin.1994.1137  1
1994 Sun KT, De Groof M, Yi J, Hansen HW, Chen K, Czernin J, Phelps ME, Schelbert HR. Quantification of the extent and severity of perfusion defects in canine myocardium by PET polar mapping. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 35: 2031-40. PMID 7989988  1
1994 Schelbert H, Czernin J. Cardiological applications of positron emission tomography Wiener Klinische Wochenschrift. 106: 487-495. PMID 7941597  1
1994 Czernin J, Schelbert HR. Non-invasive quantification of myocardial blood flow and flow reserve using dynamic positron emission tomography Wiener Klinische Wochenschrift. 106: 478-486. PMID 7941596  1
1993 Mullani NA, Choi Y, Huang SC, Hawkins RA, Dahlbom M, Hoh CK, Czernin J, Phelps ME, Schelbert HR. Is the Patlak graphical analysis method applicable to measurement of myocardial blood flow with nitrogen-13-ammonia? [11] Journal of Nuclear Medicine. 34: 1831-1834. PMID 8410314  1
1993 Czernin J, Müller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Schelbert HR. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation. 88: 62-9. PMID 8319357  1
1993 Choi Y, Huang SC, Hawkins RA, Kuhle WG, Dahlbom M, Hoh CK, Czernin J, Phelps ME, Schelbert HR. A simplified method for quantification of myocardial blood flow using nitrogen-13-ammonia and dynamic PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 34: 488-97. PMID 8280197  1
1992 Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krivokapich J, Phelps ME, Schelbert HR. Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. Journal of the American College of Cardiology. 20: 979-85. PMID 1527310 DOI: 10.1016/0735-1097(92)90201-W  1
1992 Porenta G, Kuhle W, Czernin J, Ratib O, Brunken RC, Phelps ME, Schelbert HR. Semiquantitative assessment of myocardial blood flow and viability using polar map displays of cardiac PET images. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 33: 1628-36. PMID 1517836  1
1992 Porenta G, Czernin J, Schelbert H. Positron emission tomography: Principles and applications in cardiology Wiener Medizinische Wochenschrift. 142: 358-367. PMID 1481541  1
1992 Porenta G, Kuhle W, Czernin J, Ratib O, Brunken RC, Schelbert HR. Interactive user-friendly image analysis of cardiac PET images on a low cost desktop computer Computers in Cardiology. 245-248.  1
1991 Stefenelli T, Sochor H, Slama B, Czernin J, Pachinger O, Probst P. Transient myocardial perfusion abnormalities during cold provocation test in patients with arterial hyperreactivity Zeitschrift Fur Kardiologie. 80: 622-626. PMID 1771961  1
1991 Ederle K, Kneussl M, Czernin J, Mlczoch J, Kummer F. Allergic alveolitis or intrinsic asthma: Comment on the publication in Pneumologie 44 (1990) 910-912 Pneumologie. 45: 67.  1
1990 Kneussl M, Czernin J, Mlczoch J, Kummer F. Allergic alveolitis or intrinsic asthma? Pneumologie. 44: 910-912. PMID 2399243  1
1990 Schelbert HR, Czernin J. Editorial: Noninvasive quantification of regional myocardial blood flow: Assessment of myocardial perfusion reserve and collateral circulation Journal of Nuclear Medicine. 31: 271-273. PMID 2137874  1
1989 Hochmeister MN, Seifert D, Smetana R, Czernin J. Suicide attempted by aiming slaughtering gun at pacemaker. The American Journal of Forensic Medicine and Pathology. 10: 268. PMID 2782308  1
1988 Weidinger F, Sochor H, Czernin J, Pospischil E, Glogar D. Characteristics of transient ischaemic episodes in patients with silent and symptomatic exercise-induced myocardial ischaemia European Heart Journal. 9: 1081-1087. PMID 3208774  1
1988 Smetana R, Kopsa H, Czernin J, Pilnacek M, Pospischil E, Hochmeister M, Sommer G. Heavy work under heat stress and renal burden | HITZESCHWERARBEIT UND RENALE BELASTUNG Nieren- Und Hochdruckkrankheiten. 17: 215-218.  1
1987 Stefenelli T, Glogar HD, Sochor H, Czernin J, Probst P. Myocardial ischaemia with angiographically normal coronary arteries. Pointers to a vasospastic genesis Deutsche Medizinische Wochenschrift. 112: 1580-1582. PMID 3665738  1
Show low-probability matches.